NCC-PDI, one of five FDA Pediatric Device Consortia grant programs supporting the development and commercialization of pediatric medical devices, is led by the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children’s National Health System and the A. James Clark School of Engineering at the University of Maryland. The consortium recently added new accelerators BioHealth Innovation and MedTech Innovator and design firm partner, Smithwise.
As a finalist, the following companies are receiving pitch coaching through BioHealth Innovation’s Entrepreneurs-In-Residence Program:
- AMB Surgical, LLC, Dayton, Ohio—FLYTE
- Auctus Surgical, Inc., San Francisco, Calif.—Auctus Surgical Dynamic Spinal Tethering System
- Adallo Spine, LLC, Charlottesville, Va.—Adallo implant technology
- Mighty Oak Medical, Englewood, Colo.—FIREFLY
- ActivArmor, Pueblo, Colo.—ActivArmor
- OCBrace, Orange, Calif.—OCBrace
- Children’s National Health System, Washington, D.C.– Babysteps
- Intellirod Spine, Akron, Ohio—iLink Force Sensor
- ApiFix Ltd, Boston, Mass.—ApiFix’s Minimally Invasive Deformity Correction (MID-C) System
- Nostopharma, Bethesda, Md.—Delivery device platform
- nView Medical, Salt Lake City, Utah—Surgical scanner
- Materialise, Plymouth, Mich.—SurgiCase Orthopaedics system
“We hope that through this funding opportunity we are able to motivate device companies to develop innovative technologies for pediatric orthopedic surgeons so they are well equipped to correct children’s orthopedic and spine conditions,” says Kolaleh Eskandanian, Ph.D., MBA, PMP, vice president and chief innovation officer at Children’s National Health System and principal investigator of NCC-PDI. “This competition aims to increase the profile of companies by exposing them to a panel of industry leaders who may become future investors or strategic partners.”
The finalists were selected from a high-quality pool of applicants. At the live event, the judges will select the winners based on their pitch presentations and responses to judges’ questions. Representing diverse backgrounds in business, healthcare, regulatory and intellectual property, the judges are leading executives and clinicians from BARDA, Baxter, BioHealth Innovation, Children’s Hospital of Philadelphia, Children’s National, DePuy Synthes, Epidarex Capital, Georgia Institute of Technology, Green Sun Medical, HOYA, Illumina Ventures, Johnson & Johnson, MedTech Innovator, Medtronic, Oblon, Smithwise, Texas Scottish Rite Hospital for Children and Ximedica.
The competition also features a patient advocacy panel discussion that examines why it is important to incorporate the patient’s perspective into the research and development of innovative pediatric products. The panel will feature Laurie Strongin, CEO of Hope for Henry Foundation, a nonprofit that is reinventing how hospitals care for seriously ill children and their families through innovative programs that entertain, reduce stress and empower children to be active participants in their own care.
With its eighth competition in six years, NCC-PDI has a proven track record of connecting the finalists and winners with its network of medtech executives, investors, specialty pediatricians and FDA regulatory consultants who help accelerate the process of bringing innovative medical devices to market. To date, NCC-PDI has assisted over 88 medical device companies from around the world and helped five companies receive FDA or CE Mark regulatory approval. Combined, previous NCC-PDI competition winners have raised $83 million subsequent to their participation, in part because of the networking opportunities the consortium provides them.
To register to attend the competition, visit https://www.eventbrite.com/e/ncc-pdi-competition-registration-58857324843. For more information about the NCC-PDI and to apply for an upcoming pitch competition, visit https://innovate4kids.org.